A 48-year-old man with diffuse arthralgias and acute respiratory failure is diagnosed with antisynthetase syndrome
ACR/ARHP Annual Meeting 2012: Serum Antibodies Offer Useful Clinical Insights into Systemic Sclerosis
Understanding the role of autoantibodies in systemic sclerosis (SSc) may help predict the course of the disease and guide clinical trials
Tackle Tricky Lung Complications in Connective Tissue Disease
Guidance for diagnosing and treating interstitial lung disease complications
Gadolinium Compounds Provide Insights into Pathogenesis of Fibrosing Diseases
Toll-like receptors appear to play an important role in the pathogenesis of fibrotic disorders including nephrogenic systemic fibrosis and systemic sclerosis.
Studies Show Promise for Scleroderma Therapy and Prediction of Progressing Disease
Research shows that a serum from goats might be helpful in combating diffuse cutaneous systemic sclerosis (SSc)
EULAR 2012: Partnership Between Physician and Patient
Patient involvement a valuable tool, especially in less common rheumatic disorders.
EULAR 2012: Systemic Sclerosis That Doesn’t Fit the Mold
This disease presents a range of hard-to-solve clinical difficulties.
The Forward View in Rheumatology
Future leaders convene at the ACR/Arthritis Foundation Rheumatology Research Workshop to discuss cutting-edge research and career development.
ACR/ARHP Annual Scientific Meeting Plenary Highlights Targets and Treatments for Several Diseases
Promising therapeutic targets for rheumatic diseases were the focus of a plenary session here at the ACR/ARHP 2011 Annual Scientific Meeting in November. Presenters discussed discoveries and treatments for systemic sclerosis, rheumatoid arthritis, vasculitis, and Behçet’s disease.
Rheumatoid Arthritis Drugs May Cut Cardiovascular Risk
Other studies at the ACR/ARHP Annual Scientific Meeting in November examined arthritis treatment, scleroderma screening.
- « Previous Page
- 1
- …
- 8
- 9
- 10
- 11
- 12
- Next Page »